SCHEMBL6239543

SCHEMBL6239543

CCC(C)N[Si](C)(NC(C)CC)NC(C)CC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP3A4 P08684 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5689086 0.81
SCHEMBL205085 0.81 TSHR (0.36) TSHRALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL231825 0.78 TSHR (0.38) TSHRALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL17102755 0.77 ALDH1A1 (0.33) TSHRALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL31302757 0.73 SMN1; SMN2 (0.35) TSHRALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL235489 0.73 ALDH1A1 (0.35) TSHRALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL30260080 0.73 ALDH1A1 (0.35) TSHRALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL31302767 0.73 SMN1; SMN2 (0.35) TSHRALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL4217051 0.73 MMP1 (0.31) TSHRALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL19973300 0.73 ALDH1A1 (0.31) TSHRALDH1A1TP53HSP90AA1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019233579-A1 ORGANOPOLYSILOXANES THAT CROSS-LINK AT ROOM TEMPERATURE WACKER CHEMIE AG (DE) 2019-12-12 WO disclosed
EP-2820025-B1 CROSS-LINKABLE COMPOSITIONS BASED ON ORGANOSILICON COMPOUNDS WACKER CHEMIE AG (DE) 2016-02-17 EP disclosed
EP-2789656-B1 Crosslinkable compositions based on organosilicon compounds WACKER CHEMIE AG (DE) 2015-04-22 EP disclosed
US-8987373-B2 Crosslinkable compositions based on organosilicon compounds WACKER CHEMIE AG (DE) 2015-03-24 US disclosed
US-20140309370-A1 CROSSLINKABLE COMPOSITIONS BASED ON ORGANOSILICON COMPOUNDS WACKER CHEMIE AG (DE) 2014-10-16 US disclosed
EP-2789656-A1 Crosslinkable compositions based on organosilicon compounds Wacker Chemie AG (DE) 2014-10-15 EP disclosed
EP-1008149-B1 ELECTROCONDUCTIVE COMPOSITION, COMPOSITE SUITABLE FOR MAKING SAME, AND METHODS FOR PRODUCING SUCH COMPOSITION AND COMPOSITE POTTERS INDUSTRIES INC (US) 2005-06-22 EP disclosed
WO-2005028486-A1 METHODS OF REFINING SILANE COMPOUNDS HONEYWELL INTERNATIONAL INC. (US) 2005-03-31 WO disclosed
US-20050059835-A1 Methods of refining silane compounds HONEYWELL INTERNATIONAL INC. (US) 2005-03-17 US disclosed
US-6241914-B1 Electroconductive composition composite suitable for making same and methods for producing such composition and composite POTTERS INDUSTRIES, INC. 2001-06-05 US disclosed
US-4399267-A AMINE- OR OXIME-CONTAINING SILANE, MERCAPTOALKYLSILANE, SCREEN PRINTING WACKER-CHEMIE GMBH (DE) 1983-08-16 US disclosed
EP-0073446-A1 Silicone rubber with retarded skin-forming properties Wacker-Chemie GmbH (DE) 1983-03-09 EP disclosed
EP-0000929-B1 POLYSILOXANES BASED COMPOSITIONS CONVERTIBLE INTO ELASTOMERS BY CROSS-LINKING Wacker-Chemie GmbH (DE) 1981-03-18 EP disclosed
US-4211729-A Compositions containing diorganopolysiloxanes CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE, GMBH (DE) 1980-07-08 US disclosed
US-4191817-A POLYSILOXANE WITH AMINOALKYL GROUP, AMINOSILANE OR OXIMOSILANE WACKER-CHEMIE GMBH (DE) 1980-03-04 US disclosed
US-4170700-A AMINO-SILICON COMPOUND, CARBON DIOXIDE SWS SILICONES CORPORATION (US) 1979-10-09 US disclosed
US-4147855-A PHOSPHATE NITROGEN-CONTAINING HYDROLYZABLE SILANE WACKER-CHEMIE GMBH (DE) 1979-04-03 US disclosed
EP-0000929-A1 Polysiloxanes based compositions convertible into elastomers by cross-linking Wacker-Chemie GmbH (DE) 1979-03-07 EP disclosed
US-4072655-A Organosilicon compounds as additives for curable organopolysiloxane compositions WACKER-CHEMIE GMBH (DT) 1978-02-07 US disclosed
US-4026853-A Curable bituminous organopolysiloxane compositions CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DT) 1977-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059835-A1 Methods of refining silane compounds HDAC10, HDAC1, HDAC11 TSHR 3353/4885ALDH1A1 1608/4885TP53 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.